Shares of Bio Matrix Scientific Group Inc. (PINK: BMSN), a biotechnology company engaged in the development of regenerative medicine therapies and tools to treat lung, heart, circulatory system and other internal organs, are soaring in trading today.
At last check, BMSN shares were trading 33.33% higher at $0.0020 on above average volume of 180.27 million. The stock has gained more than 230% in the last three trading sessions.
BMSN shares are soaring despite there being no recent news or development related to the company. The gains, therefore, could be due to some stock promotion activity.
Shares of Cellceutix Corp. (OTC: CTIX), a development-stage biopharmaceutical company engaged in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease, are up sharply in trading today.
At last check, CTIX shares were trading 4.05% higher at $1.80 on volume of 531,643. The stock hit an intra-day high of $1.87 in trading today. Despite today’s gains, CTIX shares have fallen more than 25% in the last three trading sessions.
CTIX shares are gaining today after the company’s CEO, Leo Ehrlich, today discussed corporate developments in 2012 and the company’s plans for 2013.
Shares of A.P. Pharma Inc. (OTC: APPA), a specialty pharmaceutical company engaged in the development of pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology, are climbing in trading today.
At last check, APPA shares were trading 5.77% higher at $0.550 on above average volume of 1.29 million. The stock hit an intra-day high of $0.56 earlier today.
Earlier this month, APPA had announced that it made some key executive appointments in preparation of potential FDA approval of lead product candidate, APF530.